phenoleptil 100 mg comprimido para perros
dechra regulatory b.v. - fenobarbital - comprimido - fenobarbital 100 - fenobarbital - perros
phenoleptil 12,5 mg comprimidos para perros
dechra regulatory b.v. - fenobarbital - comprimido - fenobarbital 12,5 - fenobarbital - perros
phenoleptil 25 mg comprimido para perros
dechra regulatory b.v. - fenobarbital - comprimido - fenobarbital 25 - fenobarbital - perros
phenoleptil 50 mg comprimidos para perros
dechra regulatory b.v. - fenobarbital - comprimido - fenobarbital 50 - fenobarbital - perros
soliphen 60 mg comprimidos para perros
domes pharma - fenobarbital - comprimido - fenobarbital 60 - fenobarbital - perros
thiafeline 2,5 mg comprimidos recubiertos con pelicula para gatos comprimido recubierto con película
le vet. beheer b.v. - tiamazol - comprimido recubierto con pelÍcula - tiamazol 2,50 - tiamazol - gatos
thiafeline 5 mg comprimidos recubiertos con pelicula para gatos comprimido recubierto con película
le vet. beheer b.v. - tiamazol - comprimido recubierto con pelÍcula - tiamazol 5 - tiamazol - gatos
vidalta 10 mg comprimidos de liberacion prolongada para gatos comprimido de liberación prolongada
merck sharp & dohme animal health s.l. - carbimazol - comprimido de liberaciÓn prolongada - - carbimazol - gatos
vidalta 15 mg comprimidos de liberacion prolongada para gatos comprimido de liberación prolongada
merck sharp & dohme animal health s.l. - carbimazol - comprimido de liberaciÓn prolongada - - carbimazol - gatos
adcetris
takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - agentes antineoplásicos - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.